AstraZeneca PLC (AZN)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
Q1  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 317.27% | 41,309 | 0.02 | |
Q4  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 13,020 | 0.01 | |
Q4  2017 | |||||
≡ | Dodge & Cox | Add 0.42% | 154,100 | 0.01 | |
Q1  2017 | |||||
≡ | Dodge & Cox | Add 14.88% | 4,858,490 | 0.24 | |
Q4  2016 | |||||
≡ | Dodge & Cox | Add 17.56% | 4,878,210 | 0.22 | |
Q3  2016 | |||||
≡ | Dodge & Cox | Add 36.25% | 7,391,400 | 0.44 | |
Q2  2016 | |||||
≡ | Dodge & Cox | Add 17.86% | 3,089,773 | 0.18 | |
Q1  2016 | |||||
≡ | Dodge & Cox | Add 128.71% | 9,735,800 | 0.51 | |
Q4  2015 | |||||
≡ | Dodge & Cox | Buy | 7,564,200 | 0.48 | |
Q4  2013 | |||||
≡ | Francis Chou - Chou Associates | Buy | 26,000 | 0.25 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.